Project Template

Table of Contents

Burundi Vaccination Drive 4 Purpose for the project 4 Project Scope Statement 5 Project objectives 6 Project requirements 7 Project risks 8 Milestone schedule (summary) 9 Budget (summary) 11 Criteria for project approval 12 Project Authority 13 Project manager and authority level 13 Project sponsor or customer and authority level 14 References 15

Burundi Vaccination Drive

Lavender Company has been contracted by Vaccines For All to help initiate their proposed project to supply vaccines to third world countries in need. The selected country, Burundi, will receive shipments of vaccines for MMR (measles, mumps, and rubella). The project will be funded by Vaccines For All and vaccines donated by Merck Foundation. These vaccines, commercially available, will then be shipped to Burundi and distributed to local outreach foundations to supply to the people. Lavender Company will work with these entities to ensure the shipments reach the community they are intended to serve.

Purpose for the project

Project Scope Statement

The scope of this project involves Vaccines for All to establish a vaccination program that serves an underdeveloped country specifically, Burundi to decrease MMR infections. Lavender Company is the project management organization (PMO) hired to organize processes to ensure donated materials are allocated, managed, and administered to the children of Burundi in hopes of achieving herd immunity and alleviating financial burdens to the local economy. Phases of this project will include establishing agreements and/or contracted services needed, locations to provide vaccination and management of those services.

Boundaries of this project will be identical to any project not fully funded. Donated vaccines and funds will be necessary to ensure this project is successful. Without the partnership from Merck and other organizations, this vaccine drive will struggle to maintain momentum. The existing political situation of the country and limited resources will continue to be an uphill battle however the aim is to build a sustainable program that produces declining results of infections through value add, and valid data, leading to herd immunity and hope for future children of Burundi.

Objectives#	Success criteria
1.Secure Funding for project	Gain support from Merck and other organizations which includes establishing contracts with local and independent subcontractors, along with materials needed for each phase of the project Develop contingency plan for project by 3/22/21
2.Complete groundwork for project	Establish paper and electronic standard of work for documenting vaccination administration by 4/9/21 Establish standard work for delivery and storage of vaccine by 4/16/21 Interview and assign political and environmental liaison by 4/23/21 Interview and assign a financial and supply chain manager to ensure product is maintained and distributed appropriately by 4/30/21 Establish workforce needs by 5/14/21
3.Scope of the project met	Vaccine drive created in multiple locations, infection rates show significant declination, and a sustainable program exists by 2022
4.Project cost	Project completed and is under the proposed budget of 855K by 2022
5. Stakeholder satisfaction met	All requirements for stakeholders and clients are met by the completion of the project in 2022
6. Data achieved to support the development of project	Herd immunity, 96% vaccination for children of Burundi (Zhou et al., 2004).
7.Customer Relationships Maintained	No conflict resulted as of cultural, religious or different ideologies and client has provided a written referral for services by end of project

Project requirements

· Must utilize the commercially available MMR II vaccine by Merck

· cost of 10 pack of 1 dose vials available at $21.71/dose (“Vaccines for Children Program”, 2021)

· alternative ProQuad, which includes varicella (chickenpox) at $137.52/dose (“Vaccines for Children Program”, 2021)

· vaccines must be kept at typical refrigeration temperatures (2 - 8℃)

· Must provide adequate diagnostic criteria to aid community health workers for the diagnosis of measles, mumps, rubella cases:

· Measles (3 C’s): cough, conjunctivitis, cold-like symptoms, trunk rash (“Measles (Rubeola)”, 2020)

· Mumps: swelling of parotid salivary glands, fever, antibody tests (“Chapter 9: Mumps, n.d.)

· Rubella: facial rash, lymph node enlargement (“Rubella (German Measles, Three-Day Measles”, 2020)

· Need to cooperate with Burundi government and World Health Organization (WHO)

· WHO oversees vaccination and surveillance efforts in the region

· Need to provide vaccination against yellow fever, hepatitis A/B, typhoid, cholera, rabies, meningitis, polio, MMR, Tdap, chickenpox, shingles, pneumonia, influenza, and malaria prophylaxis to volunteers/workers (“Burundi Traveler View”, 2020)

· as well as medical treatment for workers who may become ill from circulating diseases, including malaria

Overall project risks

· Need to provide adequate security to protect workers from anti-vaccination violence, possible threats of terrorism and robbery

· political and militia violence in neighboring countries

· Must provide adequate PPE capable of protection against MMR, as well as Ebola virus due to ongoing/persistent threat of Ebola virus

· Ebola outbreaks in neighboring Democratic Republic of the Congo threatens health and safety of community health workers

· Economic downturns in sponsor countries may result in lower numbers of donated vaccines available for use

· as well as funding for workers, supplies, transportation

· Natural disaster risks to include droughts, floods, and landslides

· natural disasters greatly increase the risk of epidemics, especially cholera

Milestone schedule

The vaccine drive, in this case, will address MMR (Measles, Mumps, and Rubella) vaccination among children in Burundi, a third-world country. To ensure that the project is successful, there have to be project milestones that will help identify the project's success and the phase that the project has reached. The milestones in this project will show the progress of the project from the commencement of the project.

The first milestone that will have to achieve before the commencement of the project is research. As the two companies source for funding and donations, they will deploy Burundi teams to conduct research. The research will enable the two organizations to identify Burundi areas with a high prevalence of the diseases that will vaccinate during the vaccine drive. That will enable the two organizations to identify the areas they should start with and those they should concentrate on. It will also enable the organizations to determine the number of people deployed per area and the vaccines that will be needed for the project.

After the research and data collection, the second milestone will be getting the legal permit to continue with the project and advertising in Burundi. That will create awareness about the project, making the country's residents' purpose take their children to be vaccinated. While advertising, the organizations will have a schedule that will be followed. Thus, the advertising should be done after the research is conducted.

The third milestone will be shipping the resources needed for the projects, such as the vaccines, coolers, freezers, syringes, and vans used for the vaccine drive. Additionally, the two organizations should secure a location used as an office and a storage facility for the project resources. The organizations will then secure other regional locations where the project will support the resources' storage depending on the locations that the vaccine drives will conduct.

The fourth milestone will be initiating the vaccine drives in several regions in Burundi concurrently. That will ensure that the project has a broad reach. The data of the children that will be vaccinated will be recorded electronically. That will help identify the number of children that have been vaccinated during the project. It will be a criteria to measure the project's reach, thus showing the project's level of success.

Budget or pre-approved financial resources

During the project, the two organizations that are in charge will be required to prepare a budget. The budget will be used to ensure that the project is a success as it will ensure optimal allocation of the financial resources. It will also indicate the expenses that will be incurred during the problem.

Criteria for project approval

Project Authority

The Lavender Co. is the assigned project manager for Vaccines for All. which is the customer. The table below outlines the authority on using organizational resources. The project sponsor will be the senior lead and holds overall accountability for the project.

Project manager and authority level

Chelsea Conner is the lead project manager for Lavender Co. and will direct and delegate tasks to the project team to conduct the project for Vaccines for All. Chelsea will track the milestones, the budget, host weekly meetings, identify and mitigate project risks, and ensure all the project requirements are met. Should Vaccines for All have any concerns or additional requirements for the project, they will report directly to Chelsea who will identify the person within Lavender Co. to handle the issue. Any statements of work (SOW) or change orders related to the project will first go through Chelsea. Chelsea will be the authoritative signer of the initial project definition and the completed project report to provide to the sponsor.

Project sponsor or customer and authority level

References